Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia

Endoscopy

Volumn 40, Issue 5, 2008, Pages 388-392

  Hernandez, J C ^a   Reicher, S ^a   Chung, D ^a   Pham, B V ^a   Tsai, F ^a   Disibio, G ^a   French, S ^a   Eysselein, V E ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BALLOON; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CLINICAL TRIAL; EPITHELIUM DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REMISSION; REPEAT PROCEDURE; TREATMENT OUTCOME;

ADULT; AGED; BALLOON DILATATION; BARRETT ESOPHAGUS; CATHETER ABLATION; ENDOSCOPES, GASTROINTESTINAL; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 43849104293     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995747     Document Type: Article

References (23)

1. Hirota WK, Loughney TM, Lazas et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277-285
2. Rokainen J, Aro P, Storskrubb Tet al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129: 1825-1831
3. Shaheen NJ. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2005; 128: 1554-1556
4. Sharma P, Faulk GW, Weston AP et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006: 4: 566-572
5. Sharma VK, Wang K, Overholt B et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barretts esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007; 65: 185-195
6. Barr H, Stone N, Rembacken B. Endoscopic Therapy for Barrett's Oesophagus. Gut 2005; 54: 875-884
7. Basu KK, Pick B, Bale R et al. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 2002; 51: 776-780
8. Ban S, Mino M, Norman N et al. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Am j Surg Path 2004; 28: 1466-1473
9. Van Laethem JL, Peny MO, Salmon I et al. Intramucosal adenocarcinoma. arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000: 46: 574-577
10. Mino-Kenudso M, Ban S, Ohana M et al. Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after porfimer-polydynamic therapy. Am J Surg Pathol 2007; 3: 403-409
11. Biddlestone LR, Barham CP, Wilkinson SP et al. The histopathology of treated Barrett's esophagus; squamous reepithelialization after acid suppression and laser photodynamic therapy. Am J Surg Pathol 1998; 22: 239-245
12. Ganz RA, Utley DS, Stern R et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in human esophagus. Gastrointest Endosc 2004; 60: 1002-1010
13. Ganz RA, Batts K. Pilot human study of a balloon-based electrode for ablation of esophageal epithelium: results in subjects prior to planned esophagectomy. Gastrointest Endosc 2004; 59: AB252
14. Sharma VK, Overholt B, Wang K et al. A randomized, multi-center evaluation of ablation of nondysplastic short segment Barrett esophagus using BAÂRRX bipolar balloon device: extended follow-up of the Ablation of Intestinal Metaplasia (AIM-1) Trial. Gastrointest Endosc 2005; 61: T1391
15. Hornick J, Blount P, Sanchez C et al. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol 2005; 29: 372-380
16. Sharma VY, McLaughlin R, Dean P et al. Successful ablation of Barrett's esophagus (BE) with low grade dysplasia (LGD) using BÂARX bipolar balloon device: preliminary results of the Ablation of Intestinal Metaplasia with LGD (AIM-LGD) Trial. Gastrointest Endosc 2005; 61: S1205
17. Barewal H, Ramsey L, Sharma P et al. Biomarker studies reversed in Barrett's esophagus. Am J Gastoenterol 1999; 94: 2829
18. Sampliner RE, Faigel D, Fennerty MB et al. Effective and safe reversal of nondysplastic Barrett's esophagus with thermal ellectrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 2001; 53: 554-558
19. Hernandez JC Tsai F, Reicher S et al. Frequency of buried Barrett's metaplasia after BAM ablation for intestinal metaplasia with or without dysplasia. Gastrointest Endosc 2007; 65AB: 111
20. Barr H. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy. Gastrointest Endosc Clin N Am 2000; 10: 421-438
21. Weston A Sharma P, Banedee S et al. Visible endoscopic and histologic changes in the cardia, before and after complete Barrett's esophagus ablation. Gastrointest Endosc 2005: 61: 515-521
22. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow up in 100 patients. Gastrointest Endosc 1999; 49: 1-7
23. Shand A, Dallal H, Palmer K et al. Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation. Gut 2001; 48: 580-581